These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 3774860)

  • 1. [Synthesis of N-alpha-(2-naphthylsulfonylglycyl-4-aminomethyl- and -4-amino-phenylalaninepiperidide as thrombin inhibitors].
    Horn H; Wagner G
    Pharmazie; 1986 Jul; 41(7):509. PubMed ID: 3774860
    [No Abstract]   [Full Text] [Related]  

  • 2. [Synthesis of N-alpha-(2-naphthylsulfonylgylcyl)-4-guanidino- and -4-guanidinomethylphenylalanine piperidide as thrombin inhibitors].
    Horn H; Wagner G
    Pharmazie; 1986 Sep; 41(9):660. PubMed ID: 3797459
    [No Abstract]   [Full Text] [Related]  

  • 3. [Modification of thrombin activity by synthetic serine proteinase inhibitors].
    Walsmann P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(4):471-82. PubMed ID: 4121340
    [No Abstract]   [Full Text] [Related]  

  • 4. Design, synthesis and testing of amino-bicycloaryl based orally bioavailable thrombin inhibitors.
    Rewinkel JB; Lucas H; Smit MJ; Noach AB; van Dinther TG; Rood AM; Jenneboer AJ; van Boeckel CA
    Bioorg Med Chem Lett; 1999 Oct; 9(19):2837-42. PubMed ID: 10522702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A short synthesis of argatroban. a potent selective thrombin inhibitor.
    Cossy J; Belotti D
    Bioorg Med Chem Lett; 2001 Aug; 11(15):1989-92. PubMed ID: 11454464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of potent and highly selective thrombin inhibitors.
    Hilpert K; Ackermann J; Banner DW; Gast A; Gubernator K; Hadváry P; Labler L; Müller K; Schmid G; Tschopp TB
    J Med Chem; 1994 Nov; 37(23):3889-901. PubMed ID: 7966150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental studies on the antithrombotic action of a highly effective synthetic thrombin inhibitor.
    Kaiser B; Markwardt F
    Thromb Haemost; 1986 Apr; 55(2):194-6. PubMed ID: 3814237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure-activity relationships of potent thrombin inhibitors: piperazides of 3-amidinophenylalanine.
    Stürzebecher J; Prasa D; Hauptmann J; Vieweg H; Wikström P
    J Med Chem; 1997 Sep; 40(19):3091-9. PubMed ID: 9301673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic low molecular weight inhibitors of thrombin.
    Geratz JD
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(4):455-70. PubMed ID: 4121339
    [No Abstract]   [Full Text] [Related]  

  • 10. HPLC Determination of the synthetic thrombin inhibitor N alpha-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide in biological material.
    Paintz M; Richter M; Hauptmann J
    Pharmazie; 1987 May; 42(5):346. PubMed ID: 3671450
    [No Abstract]   [Full Text] [Related]  

  • 11. From selective substrate analogue factor Xa inhibitors to dual inhibitors of thrombin and factor Xa. Part 3.
    Dönnecke D; Schweinitz A; Stürzebecher A; Steinmetzer P; Schuster M; Stürzebecher U; Nicklisch S; Stürzebecher J; Steinmetzer T
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3322-9. PubMed ID: 17462889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient synthesis of an enantiopure beta-lactam as an advanced precursor of thrombin and tryptase inhibitors.
    Annunziata R; Benaglia M; Cinquini M; Cozzi F; Maggioni F; Puglisi A
    J Org Chem; 2003 Apr; 68(7):2952-5. PubMed ID: 12662075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of inhibitors of thrombin on porcine aortic smooth muscle cells in primary culture.
    Melzig M; Harms C; Teuscher E; Voigt B; Wagner G
    Biomed Biochim Acta; 1986; 45(9):1199-202. PubMed ID: 3814109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synthesis of N alpha-(benzoylglycyl)- and N alpha-(benzyloxycarbonylglycyl)-4-amidinophenylalanine amides as thrombin inhibitors].
    Voigt B; Wagner G
    Pharmazie; 1985 Aug; 40(8):527-9. PubMed ID: 4080795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. O-methylated catechol metabolites of 3-(3-hydroxy-phenyl)-N-propyl piperidine (3-PPP): synthesis, pharmacological and acute toxicological evaluation.
    Thorberg SO; Ahlénius S; Johansson L; Lundström J; Säfholm C; Teiling A; Lennmark M
    Acta Pharm Suec; 1987; 24(4):183-92. PubMed ID: 3439467
    [No Abstract]   [Full Text] [Related]  

  • 16. Structure-based organic synthesis of unnatural aeruginosin hybrids as potent inhibitors of thrombin.
    Hanessian S; Ersmark K; Wang X; Del Valle JR; Blomberg N; Xue Y; Fjellström O
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3480-5. PubMed ID: 17428662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orally active thrombin inhibitors. Part 2: optimization of the P2-moiety.
    Lange UE; Baucke D; Hornberger W; Mack H; Seitz W; Höffken HW
    Bioorg Med Chem Lett; 2006 May; 16(10):2648-53. PubMed ID: 16460939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships of new NAPAP-analogs.
    Steinmetzer T; Schweinitz A; Künzel S; Wikström P; Hauptmann J; Stürzebecher J
    J Enzyme Inhib Med Chem; 2002 Apr; 17(2):241-9. PubMed ID: 12420761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Synthesis of 4-acyl-4-(3-chlorophenyl)-1-dialkylaminopropyopropyl)-piperidines. II. Synthesis of 4-acyl-4-(3-chlorophenyl)-1-(3-dialkylaminopropyl)-piperidines].
    Rylski L; Pac-Pomarnacka E
    Acta Pol Pharm; 1976; 33(2):163-7. PubMed ID: 937019
    [No Abstract]   [Full Text] [Related]  

  • 20. [Synthesis and in vitro antimicrobial activity of N-substituted derivatives of phenylpiperidine and phenylpiperazine].
    Morlacchi F; Trapani G; Losacco V; Armenise D
    Farmaco Sci; 1985 Sep; 40(9):671-82. PubMed ID: 3908142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.